BIO.News Newsletter

We’re staying on top of all the coronavirus news, including a Texas House of Representatives hearing yesterday, where we testified on government and business preparedness and response. We’re also reading a food innovation thought leader’s new blog on why our brains make certain food choices—and how we can use that knowledge to combat myths about food biotech. Here are around 870 words, or 4 minutes, 20 seconds.

We launched a Coronavirus Business Resource Center to help companies navigate the coronavirus—keep reading for details. We also have news on whether or not Congress will self-quarantine, as well as a podcast on sustainable food innovations driven by biotech to help you take your mind off the coronavirus, in 765 words, 3 minutes, 50 seconds.

It’s Podcast Monday. I AM BIO Episode 4, Trying Our Patients, is now available—and if you care about the impact of drug pricing legislation on new cures, you won’t want to miss it. Don’t forget to rate, review, and subscribe wherever you get your podcasts. (Apple, Spotify, and Google)While the spread of the coronavirus and the administration’s “shift in tone” will dominate the news this week, we also want to take a look at two other important issues for the biotech industry: the truth about…

It was another busy week in the fight to contain the coronavirus—but policymakers and the biopharma industry are coming together to find solutions. Here’s the latest news from Washington and BIO members, in about 700 words, or 3 and a half minutes.

There’s more news today on the coronavirus response, including what to expect from the emergency funding package as well as a new partnership between two BIO members, Vir and Alnylam. Be sure to check back tomorrow for more details. In the meantime, we’ve got a recap of yesterday’s hearing on how to address the plastic waste crisis, as well as more on the CAR T-cell payment problem, in about 800 words, just under 4 minutes.

We’re halfway through the week. Today, BIO CEO Jim Greenwood published a must-read op-ed in Morning Consult about the industry’s coronavirus response. We’re also looking at why biotech is key to a healthy diet, and the latest coronavirus news from Capitol Hill, in 815 words, or about 4 minutes.

We’re halfway through the week. Today, BIO CEO Jim Greenwood published a must-read op-ed in Morning Consult about the industry’s coronavirus response. We’re also looking at why biotech is key to a healthy diet, and the latest coronavirus news from Capitol Hill, in 815 words, or about 4 minutes.

What was more shocking: the South Carolina primary and how it changed the Democratic race just days ahead of Super Tuesday, or Trump’s third-ever appearance in the press briefing room on Saturday? Tweet us your thoughts at @IAmBiotech. The coronavirus continues to dominate the news today. BIO member companies are in town to join President Trump at the White House to discuss efforts to contain the outbreak, and Vice President Pence will close the day with a media briefing at 5:00 PM. Keep an eye…

What was more shocking: the South Carolina primary and how it changed the Democratic race just days ahead of Super Tuesday, or Trump’s third-ever appearance in the press briefing room on Saturday? Tweet us your thoughts at @IAmBiotech. The coronavirus continues to dominate the news today. BIO member companies are in town to join President Trump at the White House to discuss efforts to contain the outbreak, and Vice President Pence will close the day with a media briefing at 5:00 PM. Keep an eye…

We’re closing a crazy week with a recap of all the coronavirus and biofuels news you might have missed, plus a reminder about Rare Disease Day (tomorrow) and why we need to protect the Orphan Drug Act, in about 760 words, just under 4 minutes.  Enjoy the weekend. Don’t panic. Wash your hands.